Why bother the CEO with an email asking whether th
Post# of 72440
(Total Views: 395)
Posted On: 05/19/2019 1:15:06 PM
Why bother the CEO with an email asking whether the press release, which clearly stated that the term sheet was for "Ulcerative Proctitis/Proctosigmoiditis," meant that it was for ulcerativeproctitis/proctosigmoiditis, and not other things?
OF COURSE oral mucositis was not involved in the term sheet. The claim that it was included was part of the false narrative of the bashers. And then when they realized that no one was buying their story, or maybe when they decided that they have monopolized message boards enough with that nonsense, some of them changed their false narrative to "no one wants the OM formulation" which is an absurd and desperate twisting of the information that we have.
None of us wrote the CEO with an inquiry because we knew IT WAS NOT NECESSARY.
OF COURSE oral mucositis was not involved in the term sheet. The claim that it was included was part of the false narrative of the bashers. And then when they realized that no one was buying their story, or maybe when they decided that they have monopolized message boards enough with that nonsense, some of them changed their false narrative to "no one wants the OM formulation" which is an absurd and desperate twisting of the information that we have.
None of us wrote the CEO with an inquiry because we knew IT WAS NOT NECESSARY.
(6)
(0)Innovation Pharmaceuticals Inc (IPIX) Stock Research Links
Scroll down for more posts ▼